PubRank

Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement

Clinical Trial ID NCT00537823

PubWeight™ 0.78‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00537823

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004 55.13
2 Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004 49.02
3 Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004 30.26
4 Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004 18.93
5 Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990 11.57
6 Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 1992 8.98
7 Liver regeneration. Hepatology 2006 7.52
8 Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006 5.78
9 Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol 2005 3.88
10 Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 2001 3.28
11 Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006 3.05
12 Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 2005 3.04
13 Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004 2.65
14 Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab. J Surg Oncol 2005 2.47
15 Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J Clin Oncol 2005 2.38
16 Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg 2006 2.37
17 Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 2003 2.04
18 Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol 2006 2.02
19 Liver regeneration. J Am Coll Surg 2003 1.79
20 Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. Ann Oncol 2005 1.67
21 Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab. J Clin Oncol 2005 1.52
22 Stapler hepatectomy is a safe dissection technique: analysis of 300 patients. World J Surg 2006 1.38
23 Randomized clinical trial of liver resection with and without hepatic pedicle clamping. Br J Surg 2006 1.14
24 Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study. J Clin Oncol 2005 0.94
25 Optimal abdominal incision for partial hepatectomy: increased late complications with Mercedes-type incisions compared to extended right subcostal incisions. World J Surg 2006 0.88
26 Liver regeneration and splenic enlargement in donors after living-donor liver transplantation. World J Surg 2005 0.83
27 Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies. Zentralbl Chir 2003 0.82
28 The addition of bevacizumab to FOLFOX4 prolongs survival in relapsed colorectal cancer: interim data from the ECOG 3200 trial. Clin Colorectal Cancer 2005 0.80
29 Neoadjuvant chemotherapy does not increase postoperative complication rate after resection of colorectal liver metastases. Eur J Surg Oncol 2005 0.78
30 Unique site- and time-specific patterns of recurrence following resection of colorectal carcinoma hepatic metastases in patients staged by FDG-PET. J Hepatobiliary Pancreat Surg 2008 0.78
Next 100